Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (5.513)

51

Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents : a substudy of the SMILE trial

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Abdalla, S. | Compagnucci, A. | Riault, Y. | +14

52

Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab

enthalten in: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 2024

von Brosh-Nissimov, T. | Ma'aravi, N. | Leshin-Carmel, D. | +5

53

Advanced 3D Electrospinning "Xspin" System : Fabrication of Bifiber Floating Oral Pharmaceutical Scaffolds for Controlled Drug Delivery

enthalten in: Molecular pharmaceutics | 2024

von Darwesh, A. | Zhang, Y. | Aghda, N. | +2

54

Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review

enthalten in: Infection | 2024

von Fernández-de-Las-Peñas, C. | Torres-Macho, J. | Catahay, J. | +8

ErratumIn: Infection. 2024 Mar 7;:. - PMID 38451416

55

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abdullahi, A. | Diaz, A. | Fopoussi, O. | +5

56

Physiologically based pharmacokinetic modeling of ritonavir-oxycodone drug interactions and its implication for dosing strategy

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2024

von Zheng, L. | Zhang, W. | Olkkola, K. | +6

57

Nirmatrelvir/ritonavir and pharmacovigilance data

enthalten in: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease | 2024

von Lassan, S. | Gocova, M. | Solovic, I. | +3

58

Cost-Effectiveness of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the United States

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2024

von Carlson, J. | Foos, V. | Kasle, A. | +7

59

Modulation of Multidrug Resistance Protein 1-mediated Transport Processes by the Antiviral Drug Ritonavir in Cultured Primary Astrocytes

enthalten in: Neurochemical research | 2024

von Arend, C. | Grothaus, I. | Waespy, M. | +2

60

Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia

enthalten in: International journal of antimicrobial agents | 2024

von Yii, Y. | Shih, H. | Chen, C. | +5